Cancer News
Cancer operation after chemo-radiotherapy: When should it be done?
A new analysis calculates the ideal waiting time between combined chemotherapy and radiation for rectal cancer and surgical removal of the cancer.
Arzerra gets US approval against chronic lymphocytic leukemia
US regulators approved Arzerra, to be used as an extended treatment against recurrent or progressive chronic lymphocytic leukemia.
Young adult and adolescent cancer survivors worry about fertility
A new study reveals that young adult and adolescent cancer survivors, especially men, worry about their fertility and genetic risk factors.
An additional treatment option for locally advanced rectal cancer
Treating patients with advanced rectal cancer with short-course radiation followed by consolidation chemotherapy before surgery led to positive outcomes.
Positive results of everolimus in neuroendocrine tumors
Everolimus increased median progression-free survival in patients with neuroendocrine tumors of the gastrointestinal tract or unknown origin.
Treatment changes to childhood cancer extend survivors lives
Changes in pediatric cancer therapy led to decreased death rate and treatment-related death rate in childhood cancer survivors, evidence shows.
Enzalutamide appears effective in metastatic prostate cancer
A study comparing enzalutamide to bicalutamide in castration-resistant prostate cancer showed that enzalutamide increased significantly progression-free survival.
Chemotherapy-induced peripheral neuropathy: a common side effect
Chemotherapy-induced peripheral neuropathy is a common side effect for women cancer survivors, a new study reveals.
Post-treatment care for young Hodgkin lymphoma survivors
A new study identifies the gaps in post-treatment care for adolescent and young-adult Hodgkin lymphoma survivors.
Positive outcomes coming from a drug sequencing in prostate cancer
Treating patients with castration-resistant metastatic prostate cancer with docetaxel following abiraterone resulted in a 50% reduction in prostate specific antigen.
Improved survival in prostate cancer with combination treatment
Treating high-risk prostate cancer patients with anti-androgen therapy using daily bicalutamide improved their overall survival, a new research reveals.
Improving a cancer patient’s quality of life with exercise
Starting adapted fitness routines during treatment rather than waiting until afterward proved to be more beneficial for cancer patients, a new analysis reveals.
Radiation treatment reduces pancreatic cancer recurrence
Pancreatic cancer surgery patients treated also with radiotherapy together with chemotherapy lived longer, a new research found.
Afatinib seems promising for EGFR-mutated lung cancer
A study comparing afatinib than gefitinib as first-line treatment in patients with advanced lung cancer showed the effectiveness of afatinib.
The financial burden of surviving cancer
Studying medical expenditures and productivity losses in cancer patients, scientists report that the financial burden is influenced by age and cancer site.
Cabozantinib shows promise to advanced kidney cancer
A new study comparing the current standard care for renal cell carcinoma, everolimus and cabozantinib reveals the increased benefit of cabozantinib.
Childhood cancer treatments linked to heart damage
A new study reveals that childhood cancer treatments, such as certain chemotherapy and radiation, may increase the risk of heart damage in cancer survivors.
Chemical or surgical castration for prostate cancer?
A study comparing surgical to chemical castration in men with metastatic prostate cancer showed that surgical castration leads to less adverse effects.
Preserving ovarian function in breast cancer patients
Breast cancer patients who achieved ovarian suppression with the hormonal drug triptorelin had more chances to recover ovarian function, a new study shows.
Effective method to detect breast cancer-related lymphedema
Counting the symptoms of breast cancer-related lymphedema appeared to be diagnostically relevant and a cost-effective initial screening tool for lymphedema.
Screening may reduce mortality in ovarian cancer
According to the largest randomized trials in ovarian cancer, screening may reduce ovarian cancer mortality, as it can detect the disease sufficiently early.
Afatinib induces better responses in EGFR-mutated lung cancer
Afatinib appears to be more effective than gefitinib for the treatment of patients with EGFR-activating mutations in advanced lung cancer, a new study shows.
Pembrolizumab: beneficial for more lung cancer patients
The immunotherapy drug pembrolizumab could benefit patients with refractory lung cancer selected for PD-L1 expression, a new study shows.
Working while fighting cancer
Patients with advanced cancer choose to continue working after their diagnosis. However, many aspects of the disease prevent them from doing so.
Head and neck cancer: more treatment options available
Patients with difficult-to-treat and advanced head and neck cancer have more treatment options with immunotherapy and targeted therapy.
Mental health linked to risk of complications in bladder cancer
Focusing on patient-reported health status, scientists reported that the mental health of a bladder cancer patient prior to surgery affects postoperative outcomes.
Advanced melanoma: immunotherapy approved as first line treatment
The novel immunotherapy pembrolizumab was approved by the U.S. FDA as first-line treatment for metastatic melanoma.
“Poor” quality of life in thyroid cancer survivors
In a recent study assessing the physical, psychological, social and spiritual wellbeing of thyroid cancer survivors, a “poor” quality of life was reported.
Avoiding infertility and weakened defense system on chemotherapy
A new study revealed the potent humanin analogue (HNG) may help cancer patients on chemotherapy avoid infertility and a weakened defense system.
Cancer and people with mental illness
A new report provides evidence and key recommendations for medical clinicians to improve cancer prevention and treatment of people with mental illness.